Search results for "Venous thromboembolism"


 
Results 131 - 140 of about 338 for "Venous thromboembolism".
Sort by: Relevance | Newest | Oldest

Improving in-hospital handoffs

Any physicians who hand off patients may want to consider how well their messages are being understood, especially because patient safety is at stake.
https://acphospitalist.acponline.org/weekly/archives/2019/04/17/4.htm
17 Apr 2019

The battle for high-value care

Experts give their advice on value projects and the evidence on stress tests and clot prophylaxis.
https://acphospitalist.acponline.org/archives/2019/12/the-battle-for-high-value-care.htm
15 Dec 2019

Latest research looks at clots, drug therapies, and pneumonia guidance

Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/05/13/2.htm
13 May 2020

Puzzling it out together

Hospitalists share strategies for pandemic problems.
https://acphospitalist.acponline.org/archives/2020/10/puzzling-it-out-together.htm
15 Oct 2020

ACOVE quality indicators may improve care in hospitalized elderly

Clinicians administered a checklist during rounds, which assessed for prophylaxis against venous thromboembolism, indwelling bladder catheters, mobilization, and delirium evaluation—four commonly encountered components of Assessing Care of Vulnerable Elders (ACOVE).
https://acphospitalist.acponline.org/weekly/archives/2017/07/12/2.htm
12 Jul 2017

Which patients to anticoagulate and how

Updated guidelines, new drugs are among the things to know to treat venous thromboembolism.
https://acphospitalist.acponline.org/archives/2017/06/anticoagulation.htm
15 Jun 2017

Major bleeding, mortality risks after VTE similar on DOACs or warfarin

The authors noted that the safety of DOAC treatment of VTE beyond 180 days remains uncertain and that 95% of DOAC users in the study were taking rivaroxaban, so further study of other agents is needed.
https://acphospitalist.acponline.org/weekly/archives/2017/10/25/3.htm
25 Oct 2017

Preop meds, resuscitation champions, and more

Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/in-the-news.htm
15 Jun 2021

Fewer than 1% of ED patients with syncope found to have PE in retrospective analysis

The findings should discourage the adoption of routine protocols for excluding pulmonary embolism (PE) in all patients presenting to the ED with syncope, the authors said.
https://acphospitalist.acponline.org/weekly/archives/2018/02/07/3.htm
7 Feb 2018

Apixaban associated with less bleeding than warfarin for VTE in end-stage kidney disease

The use of apixaban among dialysis patients being treated for acute venous thromboembolism (VTE) rose from 2% in 2014 to 47% in 2018, according to an industry-funded retrospective comparison of the drug with warfarin.
https://acphospitalist.acponline.org/archives/2022/08/17/apixaban-associated-with-less-bleeding-than-warfarin.htm
17 Aug 2022

Result Page: Prev   9   10   11   12   13   14   15   16   17   18   Next